275 related articles for article (PubMed ID: 28928732)
21. Improving antibody affinity through
Ye W; Liu X; He R; Gou L; Lu M; Yang G; Wen J; Wang X; Liu F; Ma S; Qian W; Jia S; Ding T; Sun L; Gao W
J Biomed Res; 2022 Mar; 36(3):155-166. PubMed ID: 35545451
[TBL] [Abstract][Full Text] [Related]
22. Facile isolation of high-affinity nanobodies from synthetic libraries using CDR-swapping mutagenesis.
Zupancic JM; Desai AA; Tessier PM
STAR Protoc; 2022 Mar; 3(1):101101. PubMed ID: 35098159
[TBL] [Abstract][Full Text] [Related]
23. Antibody humanization by redesign of complementarity-determining region residues proximate to the acceptor framework.
Hanf KJ; Arndt JW; Chen LL; Jarpe M; Boriack-Sjodin PA; Li Y; van Vlijmen HW; Pepinsky RB; Simon KJ; Lugovskoy A
Methods; 2014 Jan; 65(1):68-76. PubMed ID: 23816785
[TBL] [Abstract][Full Text] [Related]
24. Construction of a large synthetic human Fab antibody library on yeast cell surface by optimized yeast mating.
Baek DS; Kim YS
J Microbiol Biotechnol; 2014 Mar; 24(3):408-20. PubMed ID: 24394194
[TBL] [Abstract][Full Text] [Related]
25. In vitro affinity maturation of an anti-PSA antibody for prostate cancer diagnostic assay.
Muller BH; Savatier A; L'Hostis G; Costa N; Bossus M; Michel S; Ott C; Becquart L; Ruffion A; Stura EA; Ducancel F
J Mol Biol; 2011 Dec; 414(4):545-62. PubMed ID: 22019475
[TBL] [Abstract][Full Text] [Related]
26. SAMURAI (Solid-phase Assisted Mutagenesis by Uracil Restriction for Accurate Integration) for antibody affinity maturation and paratope mapping.
Hu FJ; Lundqvist M; Uhlén M; Rockberg J
Nucleic Acids Res; 2019 Apr; 47(6):e34. PubMed ID: 30715449
[TBL] [Abstract][Full Text] [Related]
27. Affinity maturation of a V(H)H by mutational hotspot randomization.
Yau KY; Dubuc G; Li S; Hirama T; Mackenzie CR; Jermutus L; Hall JC; Tanha J
J Immunol Methods; 2005 Feb; 297(1-2):213-24. PubMed ID: 15777944
[TBL] [Abstract][Full Text] [Related]
28. Antibody engineering by parsimonious mutagenesis.
Balint RF; Larrick JW
Gene; 1993 Dec; 137(1):109-18. PubMed ID: 7506686
[TBL] [Abstract][Full Text] [Related]
29. The human combinatorial antibody library HuCAL GOLD combines diversification of all six CDRs according to the natural immune system with a novel display method for efficient selection of high-affinity antibodies.
Rothe C; Urlinger S; Löhning C; Prassler J; Stark Y; Jäger U; Hubner B; Bardroff M; Pradel I; Boss M; Bittlingmaier R; Bataa T; Frisch C; Brocks B; Honegger A; Urban M
J Mol Biol; 2008 Feb; 376(4):1182-200. PubMed ID: 18191144
[TBL] [Abstract][Full Text] [Related]
30. Mutational analysis of domain antibodies reveals aggregation hotspots within and near the complementarity determining regions.
Perchiacca JM; Bhattacharya M; Tessier PM
Proteins; 2011 Sep; 79(9):2637-47. PubMed ID: 21732420
[TBL] [Abstract][Full Text] [Related]
31. In vitro affinity maturation of a natural human antibody overcomes a barrier to in vivo affinity maturation.
Li B; Fouts AE; Stengel K; Luan P; Dillon M; Liang WC; Feierbach B; Kelley RF; Hötzel I
MAbs; 2014; 6(2):437-45. PubMed ID: 24492299
[TBL] [Abstract][Full Text] [Related]
32. Isolation of picomolar affinity anti-c-erbB-2 single-chain Fv by molecular evolution of the complementarity determining regions in the center of the antibody binding site.
Schier R; McCall A; Adams GP; Marshall KW; Merritt H; Yim M; Crawford RS; Weiner LM; Marks C; Marks JD
J Mol Biol; 1996 Nov; 263(4):551-67. PubMed ID: 8918938
[TBL] [Abstract][Full Text] [Related]
33. Comprehensive interrogation of a minimalist synthetic CDR-H3 library and its ability to generate antibodies with therapeutic potential.
Mahon CM; Lambert MA; Glanville J; Wade JM; Fennell BJ; Krebs MR; Armellino D; Yang S; Liu X; O'Sullivan CM; Autin B; Oficjalska K; Bloom L; Paulsen J; Gill D; Damelin M; Cunningham O; Finlay WJ
J Mol Biol; 2013 May; 425(10):1712-30. PubMed ID: 23429058
[TBL] [Abstract][Full Text] [Related]
34. A Novel Human scFv Library with Non-Combinatorial Synthetic CDR Diversity.
Bai X; Kim J; Kang S; Kim W; Shim H
PLoS One; 2015; 10(10):e0141045. PubMed ID: 26484868
[TBL] [Abstract][Full Text] [Related]
35. Optimal charged mutations in the complementarity-determining regions that prevent domain antibody aggregation are dependent on the antibody scaffold.
Perchiacca JM; Lee CC; Tessier PM
Protein Eng Des Sel; 2014 Feb; 27(2):29-39. PubMed ID: 24398633
[TBL] [Abstract][Full Text] [Related]
36. Comprehensive functional maps of the antigen-binding site of an anti-ErbB2 antibody obtained with shotgun scanning mutagenesis.
Vajdos FF; Adams CW; Breece TN; Presta LG; de Vos AM; Sidhu SS
J Mol Biol; 2002 Jul; 320(2):415-28. PubMed ID: 12079396
[TBL] [Abstract][Full Text] [Related]
37. In vitro evolution of single-chain antibodies using mRNA display.
Fukuda I; Kojoh K; Tabata N; Doi N; Takashima H; Miyamoto-Sato E; Yanagawa H
Nucleic Acids Res; 2006; 34(19):e127. PubMed ID: 17012279
[TBL] [Abstract][Full Text] [Related]
38. Fully synthetic human combinatorial antibody libraries (HuCAL) based on modular consensus frameworks and CDRs randomized with trinucleotides.
Knappik A; Ge L; Honegger A; Pack P; Fischer M; Wellnhofer G; Hoess A; Wölle J; Plückthun A; Virnekäs B
J Mol Biol; 2000 Feb; 296(1):57-86. PubMed ID: 10656818
[TBL] [Abstract][Full Text] [Related]
39. Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured Fab in complex with antigen.
Chen Y; Wiesmann C; Fuh G; Li B; Christinger HW; McKay P; de Vos AM; Lowman HB
J Mol Biol; 1999 Nov; 293(4):865-81. PubMed ID: 10543973
[TBL] [Abstract][Full Text] [Related]
40. Improvement in affinity and thermostability of a fully human antibody against interleukin-17A by yeast-display technology and CDR grafting.
Sun W; Yang Z; Lin H; Liu M; Zhao C; Hou X; Hu Z; Cui B
Acta Pharm Sin B; 2019 Sep; 9(5):960-972. PubMed ID: 31649846
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
